Profile data is unavailable for this security.
About the company
Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
- Revenue in INR (TTM)23.46bn
- Net income in INR4.01bn
- Incorporated1995
- Employees4.10k
- LocationDr. Lal PathLabs Ltd12th FloorTower B, SAS Tower, Sector 38, MedicityGURGAON 122001IndiaIND
- Phone+91 1 243016500
- Fax+91 1 244234468
- Websitehttps://www.lalpathlabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagility India Ltd | 48.61bn | 2.08bn | 136.93bn | 35.86k | 65.81 | 1.80 | 16.28 | 2.82 | 0.4445 | 0.4445 | 10.38 | 16.25 | 0.4618 | -- | 4.87 | 1,387,054.00 | 1.98 | -- | 2.21 | -- | 99.00 | -- | 4.28 | -- | -- | 2.79 | 0.166 | -- | 12.69 | -- | 58.99 | -- | -- | -- |
| Rainbow Children's Medicare Ltd | 14.25bn | 2.32bn | 160.30bn | 3.94k | 69.39 | 11.93 | 44.36 | 11.25 | 22.75 | 22.75 | 139.95 | 132.29 | 0.6851 | 7.91 | 17.84 | 3,616,084.00 | 11.17 | 9.89 | 12.04 | 10.96 | 87.45 | 82.96 | 16.31 | 13.80 | 4.12 | 5.02 | 0.3602 | -- | 10.51 | 19.03 | 2.93 | 37.23 | 32.22 | -- |
| Aster DM Healthcare Ltd | 16.42bn | 2.51bn | 215.67bn | 14.02k | 89.02 | 6.28 | 55.37 | 13.13 | 4.86 | 108.08 | 32.21 | 68.98 | 0.1467 | 1.20 | 1.26 | 1,171,811.00 | 2.85 | 2.24 | 4.16 | 3.60 | 40.82 | 59.73 | 19.40 | 4.26 | 1.82 | 7.41 | 0.3501 | -- | 23.54 | -14.22 | 12.28 | -18.15 | 6.87 | -- |
| Krishna Institute Of Medical Sciencs Ltd | 27.05bn | 3.31bn | 226.96bn | 5.01k | 68.53 | 11.34 | 43.18 | 8.39 | 8.28 | 8.28 | 67.59 | 50.03 | 0.6765 | 10.76 | 8.26 | 5,396,635.00 | 9.10 | 13.71 | 11.33 | 16.73 | 79.37 | 54.29 | 13.45 | 15.53 | 0.8678 | 8.11 | 0.4384 | 0.00 | 13.67 | 22.17 | -7.78 | -- | 52.94 | -- |
| Dr. Lal PathLabs Ltd | 23.46bn | 4.01bn | 253.36bn | 4.10k | 63.15 | 12.66 | 46.13 | 10.80 | 48.17 | 48.17 | 281.60 | 240.30 | 0.9306 | 10.55 | 26.72 | 5,724,423.00 | 16.13 | 15.49 | 20.12 | 19.38 | 80.28 | 76.13 | 17.33 | 15.99 | 2.77 | 20.16 | 0.0889 | 23.86 | 10.40 | 13.10 | 49.78 | 12.43 | 6.44 | 31.95 |
| Narayana Hrudayalaya Ltd | 52.21bn | 7.79bn | 256.31bn | 11.66k | 32.91 | 8.05 | 24.79 | 4.91 | 38.35 | 38.35 | 257.10 | 156.86 | 0.9466 | 20.96 | 9.50 | 4,477,685.00 | 14.13 | 10.79 | 18.08 | 13.97 | 60.92 | 47.11 | 14.92 | 9.72 | 1.46 | 7.62 | 0.3468 | 9.64 | 10.91 | 11.89 | 30.19 | 67.89 | 45.27 | 31.95 |
| Holder | Shares | % Held |
|---|---|---|
| Wasatch Advisors LPas of 13 Sep 2024 | 4.15m | 4.96% |
| Invesco Advisers, Inc.as of 30 Sep 2024 | 3.30m | 3.94% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Oct 2024 | 2.68m | 3.21% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 30 Jun 2024 | 2.35m | 2.82% |
| First Sentier Investors (Australia) IM Ltd.as of 30 Jun 2024 | 1.46m | 1.74% |
| SBI Funds Management Ltd.as of 31 Oct 2024 | 1.45m | 1.74% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 1.28m | 1.53% |
| Life Insurance Corporation of India (Investment Portfolio)as of 30 Jun 2024 | 1.23m | 1.47% |
| First Sentier Investors (Singapore)as of 30 Jun 2024 | 922.00k | 1.10% |
| First Sentier Investors (Hong Kong) Ltd.as of 30 Jun 2024 | 922.00k | 1.10% |
